SpyGlass Pharma, Inc.
SGP
$26.20
$1.034.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Net Income | -43.75% | -10.06% | 1.68% | ||
| Total Depreciation and Amortization | 7.55% | 46.75% | 8.06% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 29.17% | 284.98% | -64.87% | ||
| Change in Net Operating Assets | 241.52% | -168.37% | 203.53% | ||
| Cash from Operations | -9.56% | -45.10% | 22.88% | ||
| Capital Expenditure | -185.80% | -60.76% | 68.29% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 200.81% | -199.58% | -- | ||
| Cash from Investing | 44.03% | -390.06% | 68.29% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -43.64% | 177.78% | -89.00% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -100.00% | 53,474,900.00% | 54.62% | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 99.34% | -199.52% | -1,857.14% | ||
| Cash from Financing | -99.99% | 17,833.25% | 50.94% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -111.06% | 1,577.28% | 65.91% | ||